Option chain shows key data for Rapid Micro Biosystems's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Rapid Micro Biosystems.

Rapid Micro Biosystems (NASDAQ:RPID) Stock, Option Chain

Rapid Micro Biosystems

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Apple Store Fifth Avenue

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AAPL

AMGN

ARDX

AXTI

BBAI

EXPE

FTNT

JAGX

LLAP

LOCO

MRIN

NAOV

OSPN

RPID

STEM

TRUP

VAXX

Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

Long Ideas

Penny Stocks

CORT

Kintara Therapeutics, Inc. - Common Stock

KTRA

MIST

MOTS

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January

Insider Trades

ASPS

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

The Dow Jones closed higher by around 75 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Cardio Diagnostics And 2 Other Penny Stocks Insiders Are Buying

Rapid Micro Biosystems, Inc. - Class A Common Stock

Rapid Micro Biosystems Inc

The Company is reaffirming its full year 2024 total revenue guidance of at least $27.0 million, representing growth of at least 20% compared to ful...

Rapid Micro Biosystems reaffirms FY24 revenue view of at least $27M

TD Cowen analyst Brendan Smith maintained a Buy rating on Rapid Micro Biosystems (RPID – Research Report) today. The company's shares opened today ...

TD Cowen Reaffirms Their Buy Rating on Rapid Micro Biosystems (RPID)

Rapid Micro Biosystems, Inc. (RPID) Q3 2024 Earnings Call Transcript

Rapid Micro Biosystems, Inc. Class A ( ($RPID) ) has released its Q3 earnings. Here is a breakdown of the information Rapid Micro Biosystems, Inc. ...

Rapid Micro Biosystems Reports Strong Q3 2024 Growth

Consensus $27.45M. The company said, "The Company expects full year 2024 revenue of approximately $28.1 million, representing growth of approximate...

Rapid Micro Biosystems raises FY24 revenue view to $28.1M from at least $27M

The company said, "The Company expects record fourth quarter 2024 revenue of approximately $8.2 million, representing growth of approximately 30% c...

Rapid Micro Biosystems reports preliminary Q4 revenue $8.2M, consensus $7.6M

Rapid Micro Biosystems (RPID) announced a collaboration with Lonza (LZAGY) integrating the Growth Direct and Lonza's MODA-EM module, creating the f...

Rapid Micro Biosystems announces QC solution collaboration with Lonza

Rapid Micro Biosystems expects Q4 revenue of about $8.2M

Check out this evening's top movers from around Wall Street, compiled by The Fly.&nbsp;&nbsp; HIGHER – 908 Devices&nbsp;(MASS)&nbsp;up 26.3% after ...

Closing Bell Movers: Vericel down 11% after Q4 pre-announcement

An update from Rapid Micro Biosystems ( ($RPID) ) is now available. On January 16, 2025, Rapid Micro Biosystems updated its corporate presentation ...

Rapid Micro Biosystems Reports Record Revenue Growth

APLD

CVGW

LASR

LZAGY

MASS

VCEL

Biotech

Press Releases

General

Rapid Micro Biosystems to Announce First Quarter 2024 Financial Results on May 3, 2024

Earnings

Rapid Micro Biosystems Reports First Quarter 2024 Financial Results

Rapid Micro Biosystems to Announce Second Quarter 2024 Financial Results on August 2, 2024

Rapid Micro Biosystems Reports Second Quarter 2024 Financial Results

Rapid Micro Biosystems to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Rapid Micro Biosystems to Announce Third Quarter 2024 Financial Results on November 1, 2024

Health Care

Rapid Micro Biosystems Reports Third Quarter 2024 Financial Results

Rapid Micro Biosystems to Participate in the Stifel 2024 Healthcare Conference

Rapid Micro Biosystems to Present at 43ʳᵈ Annual J.P. Morgan Healthcare Conference

Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenue

Morgan Stanley

Comments

Rapid Micro Biosystems

Rapid Micro Biosystems (RPID) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga